Figure 2
From: AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker
AKR1C3 IHC H-score correlation with ALL blast percentage. Quantification of singleplex nuclear immunoreactivity of AKR1C3 by the H-score in B and T lymphoblastic leukemia/lymphoma among cases with IHC expression of < or ≥ 20% Grade 2 +. Correlation with disease involvement is significant in T-ALL, but not B-ALL.
